Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Opioid-Related Disorders | 13 | 2025 | 507 | 4.010 |
Why?
|
| Buprenorphine | 9 | 2025 | 192 | 3.920 |
Why?
|
| Opiate Substitution Treatment | 9 | 2025 | 206 | 2.210 |
Why?
|
| Eczema | 6 | 2023 | 9 | 1.230 |
Why?
|
| Dermatitis, Atopic | 6 | 2023 | 29 | 1.200 |
Why?
|
| Hypertension | 3 | 2023 | 585 | 1.200 |
Why?
|
| Telemedicine | 2 | 2024 | 326 | 1.170 |
Why?
|
| Narcotic Antagonists | 4 | 2025 | 136 | 1.090 |
Why?
|
| Ischemic Attack, Transient | 2 | 2017 | 96 | 1.010 |
Why?
|
| Substance Withdrawal Syndrome | 2 | 2024 | 123 | 0.930 |
Why?
|
| Antihypertensive Agents | 2 | 2015 | 166 | 0.830 |
Why?
|
| Stroke | 3 | 2017 | 1196 | 0.810 |
Why?
|
| Asthma | 5 | 2023 | 459 | 0.730 |
Why?
|
| Smoking Cessation | 7 | 2022 | 550 | 0.710 |
Why?
|
| Drug Overdose | 1 | 2023 | 131 | 0.700 |
Why?
|
| Mobile Applications | 1 | 2022 | 136 | 0.670 |
Why?
|
| Health Promotion | 2 | 2015 | 497 | 0.620 |
Why?
|
| Quality Indicators, Health Care | 2 | 2019 | 338 | 0.600 |
Why?
|
| Humans | 44 | 2025 | 63468 | 0.590 |
Why?
|
| Prisons | 6 | 2022 | 111 | 0.570 |
Why?
|
| Family Practice | 2 | 2017 | 211 | 0.550 |
Why?
|
| General Practice | 1 | 2017 | 16 | 0.540 |
Why?
|
| Dental Care | 1 | 2017 | 7 | 0.540 |
Why?
|
| Substance Abuse Treatment Centers | 1 | 2018 | 104 | 0.540 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2018 | 80 | 0.540 |
Why?
|
| Health Information Systems | 1 | 2017 | 2 | 0.540 |
Why?
|
| General Practitioners | 1 | 2017 | 15 | 0.540 |
Why?
|
| Hepatitis C, Chronic | 1 | 2018 | 88 | 0.530 |
Why?
|
| Secondary Prevention | 2 | 2017 | 164 | 0.530 |
Why?
|
| Continuity of Patient Care | 2 | 2018 | 174 | 0.510 |
Why?
|
| Smoking Prevention | 4 | 2013 | 162 | 0.500 |
Why?
|
| Evidence-Based Medicine | 1 | 2018 | 462 | 0.500 |
Why?
|
| Oral Health | 1 | 2017 | 61 | 0.500 |
Why?
|
| Aspirin | 1 | 2017 | 171 | 0.490 |
Why?
|
| Fentanyl | 4 | 2025 | 76 | 0.480 |
Why?
|
| Information Dissemination | 1 | 2017 | 116 | 0.480 |
Why?
|
| Medical Records | 1 | 2016 | 137 | 0.480 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2017 | 226 | 0.470 |
Why?
|
| Point-of-Care Systems | 1 | 2017 | 131 | 0.470 |
Why?
|
| Antiviral Agents | 1 | 2018 | 324 | 0.470 |
Why?
|
| Documentation | 1 | 2016 | 128 | 0.460 |
Why?
|
| Prisoners | 5 | 2015 | 165 | 0.460 |
Why?
|
| Healthcare Disparities | 2 | 2017 | 360 | 0.440 |
Why?
|
| Delivery of Health Care | 1 | 2017 | 435 | 0.390 |
Why?
|
| Hypersensitivity | 2 | 2023 | 64 | 0.390 |
Why?
|
| Smoking | 6 | 2022 | 866 | 0.350 |
Why?
|
| Lung Diseases | 1 | 2012 | 183 | 0.340 |
Why?
|
| Adult | 15 | 2025 | 16830 | 0.320 |
Why?
|
| Male | 17 | 2025 | 29907 | 0.300 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 836 | 0.270 |
Why?
|
| Tobacco Products | 2 | 2022 | 80 | 0.270 |
Why?
|
| Patient Preference | 3 | 2025 | 84 | 0.270 |
Why?
|
| Patient-Centered Care | 3 | 2018 | 254 | 0.270 |
Why?
|
| Longitudinal Studies | 3 | 2024 | 1256 | 0.260 |
Why?
|
| Quality Assurance, Health Care | 2 | 2019 | 255 | 0.240 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2025 | 761 | 0.240 |
Why?
|
| Students, Medical | 2 | 2025 | 262 | 0.230 |
Why?
|
| Washington | 1 | 2024 | 26 | 0.230 |
Why?
|
| Oregon | 1 | 2024 | 19 | 0.220 |
Why?
|
| Anesthetics, Dissociative | 1 | 2024 | 7 | 0.220 |
Why?
|
| Primary Health Care | 3 | 2021 | 690 | 0.220 |
Why?
|
| Smoke-Free Policy | 2 | 2015 | 9 | 0.220 |
Why?
|
| Female | 15 | 2025 | 32891 | 0.220 |
Why?
|
| Ketamine | 1 | 2024 | 38 | 0.220 |
Why?
|
| Janus Kinase Inhibitors | 1 | 2023 | 18 | 0.210 |
Why?
|
| Dermatologic Agents | 1 | 2023 | 21 | 0.210 |
Why?
|
| Students, Nursing | 1 | 2025 | 87 | 0.210 |
Why?
|
| Sublingual Immunotherapy | 1 | 2022 | 1 | 0.200 |
Why?
|
| Patient Participation | 1 | 2025 | 230 | 0.200 |
Why?
|
| Buprenorphine, Naloxone Drug Combination | 1 | 2022 | 26 | 0.190 |
Why?
|
| Practice Guidelines as Topic | 2 | 2018 | 724 | 0.190 |
Why?
|
| Naloxone | 1 | 2022 | 60 | 0.190 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2022 | 47 | 0.190 |
Why?
|
| Social Stigma | 1 | 2022 | 73 | 0.190 |
Why?
|
| Smartphone | 1 | 2022 | 69 | 0.180 |
Why?
|
| Middle Aged | 7 | 2025 | 17609 | 0.180 |
Why?
|
| Analgesics, Opioid | 2 | 2025 | 536 | 0.180 |
Why?
|
| Attitude of Health Personnel | 2 | 2025 | 596 | 0.180 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 1553 | 0.170 |
Why?
|
| United States | 7 | 2023 | 7843 | 0.170 |
Why?
|
| Young Adult | 3 | 2022 | 4696 | 0.160 |
Why?
|
| Central Nervous System Agents | 1 | 2018 | 6 | 0.150 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2018 | 9 | 0.150 |
Why?
|
| Induction Chemotherapy | 1 | 2018 | 41 | 0.150 |
Why?
|
| Substance Abuse Detection | 1 | 2018 | 45 | 0.150 |
Why?
|
| Systems Integration | 1 | 2018 | 26 | 0.140 |
Why?
|
| Cohort Studies | 1 | 2024 | 2569 | 0.140 |
Why?
|
| Benzodiazepines | 1 | 2018 | 100 | 0.140 |
Why?
|
| Osteoarthritis, Knee | 1 | 2023 | 385 | 0.140 |
Why?
|
| Knowledge Bases | 1 | 2017 | 5 | 0.130 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 464 | 0.130 |
Why?
|
| Epidemics | 1 | 2017 | 25 | 0.130 |
Why?
|
| Survival Rate | 1 | 2019 | 852 | 0.130 |
Why?
|
| Patient Compliance | 1 | 2019 | 360 | 0.130 |
Why?
|
| Motivation | 2 | 2022 | 284 | 0.130 |
Why?
|
| Health Information Management | 1 | 2016 | 1 | 0.130 |
Why?
|
| Recurrence | 1 | 2018 | 641 | 0.130 |
Why?
|
| Cotinine | 2 | 2013 | 19 | 0.130 |
Why?
|
| Clinical Medicine | 1 | 2016 | 16 | 0.130 |
Why?
|
| Physician-Patient Relations | 2 | 2018 | 419 | 0.120 |
Why?
|
| Medical History Taking | 1 | 2016 | 67 | 0.120 |
Why?
|
| Counseling | 1 | 2018 | 362 | 0.120 |
Why?
|
| Workload | 1 | 2016 | 126 | 0.120 |
Why?
|
| Efficiency, Organizational | 1 | 2016 | 96 | 0.120 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2017 | 125 | 0.120 |
Why?
|
| Homicide | 1 | 2015 | 31 | 0.120 |
Why?
|
| Poverty | 1 | 2017 | 296 | 0.110 |
Why?
|
| Hyperglycemia | 1 | 2015 | 104 | 0.110 |
Why?
|
| Blood Pressure Determination | 1 | 2014 | 37 | 0.110 |
Why?
|
| Physicians, Primary Care | 1 | 2015 | 78 | 0.110 |
Why?
|
| Burnout, Professional | 1 | 2016 | 135 | 0.110 |
Why?
|
| Reference Values | 1 | 2014 | 335 | 0.110 |
Why?
|
| Family Health | 1 | 2014 | 69 | 0.110 |
Why?
|
| Disease Management | 1 | 2015 | 232 | 0.100 |
Why?
|
| Violence | 1 | 2015 | 170 | 0.100 |
Why?
|
| Personal Autonomy | 1 | 2013 | 68 | 0.100 |
Why?
|
| Motivational Interviewing | 1 | 2013 | 43 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2023 | 771 | 0.100 |
Why?
|
| Pruritus | 2 | 2023 | 30 | 0.100 |
Why?
|
| Mass Screening | 1 | 2018 | 690 | 0.100 |
Why?
|
| Health Services Accessibility | 1 | 2017 | 564 | 0.090 |
Why?
|
| Blood Pressure | 1 | 2014 | 511 | 0.090 |
Why?
|
| Quality of Life | 3 | 2023 | 1228 | 0.090 |
Why?
|
| Emergencies | 1 | 2012 | 121 | 0.090 |
Why?
|
| Health Status | 1 | 2014 | 436 | 0.090 |
Why?
|
| Physicians | 1 | 2017 | 470 | 0.090 |
Why?
|
| Skin Diseases | 1 | 2012 | 82 | 0.090 |
Why?
|
| Surveys and Questionnaires | 3 | 2014 | 2679 | 0.090 |
Why?
|
| Aged | 3 | 2022 | 14443 | 0.080 |
Why?
|
| Adolescent | 2 | 2023 | 6254 | 0.080 |
Why?
|
| Hospitals, Urban | 1 | 2009 | 43 | 0.080 |
Why?
|
| Hospitals, University | 1 | 2009 | 54 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 696 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2014 | 2081 | 0.070 |
Why?
|
| Algorithms | 1 | 2012 | 1003 | 0.060 |
Why?
|
| Emergency Service, Hospital | 2 | 2018 | 1101 | 0.060 |
Why?
|
| Prospective Studies | 1 | 2012 | 3294 | 0.060 |
Why?
|
| Communication | 2 | 2018 | 571 | 0.060 |
Why?
|
| Patient Discharge | 1 | 2009 | 512 | 0.060 |
Why?
|
| Administration, Sublingual | 1 | 2024 | 4 | 0.060 |
Why?
|
| Tacrolimus | 1 | 2023 | 65 | 0.050 |
Why?
|
| Methadone | 1 | 2024 | 134 | 0.050 |
Why?
|
| Patient Care Team | 2 | 2009 | 337 | 0.050 |
Why?
|
| Child | 2 | 2023 | 4536 | 0.050 |
Why?
|
| Montana | 1 | 2023 | 3 | 0.050 |
Why?
|
| Biomarkers | 2 | 2023 | 1408 | 0.050 |
Why?
|
| Farmers | 1 | 2023 | 20 | 0.050 |
Why?
|
| Dermatophagoides pteronyssinus | 1 | 2022 | 2 | 0.050 |
Why?
|
| Pyroglyphidae | 1 | 2022 | 3 | 0.050 |
Why?
|
| Desensitization, Immunologic | 1 | 2022 | 12 | 0.050 |
Why?
|
| Leptin | 1 | 2023 | 85 | 0.050 |
Why?
|
| Seasons | 1 | 2023 | 134 | 0.050 |
Why?
|
| Allergens | 1 | 2022 | 53 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2022 | 122 | 0.050 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2023 | 182 | 0.050 |
Why?
|
| Immunoglobulin E | 1 | 2022 | 80 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2023 | 378 | 0.050 |
Why?
|
| Odds Ratio | 2 | 2014 | 768 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2023 | 321 | 0.040 |
Why?
|
| Nephrology | 1 | 2001 | 15 | 0.040 |
Why?
|
| Curriculum | 1 | 2025 | 599 | 0.040 |
Why?
|
| Endocrinology | 1 | 2001 | 21 | 0.040 |
Why?
|
| Group Processes | 1 | 2001 | 43 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2024 | 1008 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2025 | 689 | 0.040 |
Why?
|
| Interprofessional Relations | 1 | 2001 | 134 | 0.040 |
Why?
|
| Caregivers | 1 | 2023 | 272 | 0.040 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2001 | 157 | 0.040 |
Why?
|
| Rural Population | 1 | 2021 | 203 | 0.040 |
Why?
|
| Program Evaluation | 2 | 2017 | 487 | 0.040 |
Why?
|
| Diet | 1 | 2022 | 526 | 0.040 |
Why?
|
| Diagnostic Errors | 1 | 2018 | 101 | 0.030 |
Why?
|
| Missouri | 1 | 2017 | 10 | 0.030 |
Why?
|
| Infant | 1 | 2022 | 1650 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2023 | 790 | 0.030 |
Why?
|
| Health Policy | 1 | 2018 | 192 | 0.030 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2015 | 23 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2017 | 222 | 0.030 |
Why?
|
| Self Care | 1 | 2017 | 212 | 0.030 |
Why?
|
| Respiratory Sounds | 1 | 2015 | 22 | 0.030 |
Why?
|
| Evidence-Based Practice | 1 | 2015 | 85 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2018 | 422 | 0.030 |
Why?
|
| Rhode Island | 1 | 2015 | 100 | 0.030 |
Why?
|
| Fatigue | 1 | 2015 | 111 | 0.030 |
Why?
|
| Chest Pain | 1 | 2015 | 84 | 0.030 |
Why?
|
| Dyspnea | 1 | 2015 | 124 | 0.030 |
Why?
|
| New England | 1 | 2013 | 274 | 0.020 |
Why?
|
| Cough | 1 | 2015 | 183 | 0.020 |
Why?
|
| Intention | 1 | 2013 | 67 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2023 | 5686 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2015 | 433 | 0.020 |
Why?
|
| Dermatitis, Exfoliative | 1 | 2012 | 3 | 0.020 |
Why?
|
| Purpura | 1 | 2012 | 3 | 0.020 |
Why?
|
| Fasciitis, Necrotizing | 1 | 2012 | 4 | 0.020 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2012 | 12 | 0.020 |
Why?
|
| Blister | 1 | 2012 | 17 | 0.020 |
Why?
|
| Physical Examination | 1 | 2012 | 112 | 0.020 |
Why?
|
| Psoriasis | 1 | 2012 | 55 | 0.020 |
Why?
|
| Soft Tissue Infections | 1 | 2012 | 49 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 937 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2014 | 753 | 0.020 |
Why?
|
| Social Support | 1 | 2013 | 371 | 0.020 |
Why?
|
| Logistic Models | 1 | 2013 | 1277 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 978 | 0.020 |
Why?
|
| Cost Savings | 1 | 2009 | 54 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 2462 | 0.020 |
Why?
|
| Emergency Medical Services | 1 | 2012 | 266 | 0.020 |
Why?
|
| Boston | 1 | 2009 | 252 | 0.020 |
Why?
|
| Neoplasms | 1 | 2018 | 1364 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 3771 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2009 | 475 | 0.010 |
Why?
|
| Animals | 1 | 2022 | 20664 | 0.010 |
Why?
|
| Hospitalization | 1 | 2009 | 1361 | 0.010 |
Why?
|